Precision Minimally Invasive Surgery for Early Lung Cancer in Shanghai
The detection of early-stage lung cancer — increasingly common as low-dose CT screening becomes more widespread — presents both an opportunity and a surgical challenge. The goal is complete cancer removal with the smallest possible impact on lung function, immune capacity, and quality of life. At Fudan University Shanghai Cancer Center, Prof. Chen Haiquan has developed a surgical philosophy and technical framework that is now recognized in international guidelines as the standard for precision lung cancer surgery.
Featured Specialist: Prof. Chen Haiquan (陈海泉)
Prof. Chen Haiquan is a leading thoracic surgeon at Fudan University Shanghai Cancer Center (FUSCC) — China's premier dedicated cancer hospital. He is the originator of the "Minimally Invasive 3.0" (微创3.0) theory — a conceptual and technical framework that redefines what minimally invasive lung cancer surgery means in the modern era.
His contributions have achieved the highest level of international recognition: his research findings have been incorporated into international clinical guidelines — meaning that surgeons worldwide are now recommended to follow protocols that Prof. Chen developed and validated at FUSCC.
What Is "Minimally Invasive 3.0"?
Prof. Chen's Minimally Invasive 3.0 theory represents the third generation of minimally invasive thoracic surgery, evolving beyond earlier generations that focused primarily on incision size:
- 1.0 — Minimally invasive incision: Video-assisted thoracoscopic surgery (VATS) replacing open thoracotomy — smaller cuts, less pain
- 2.0 — Minimally invasive resection: Sublobar resection (segmentectomy, wedge resection) instead of lobectomy for small tumors — preserving more lung tissue
- 3.0 — Minimally invasive biology: Prof. Chen's innovation — preserving the patient's immune barrier by avoiding unnecessary lymph node dissection, guided by intraoperative frozen pathology to determine exactly which lymph nodes require removal
The key insight of Minimally Invasive 3.0 is that unnecessary lymph node dissection damages the immune system — removing lymph nodes that are not involved by cancer disrupts regional immune surveillance and may paradoxically worsen long-term outcomes. By using intraoperative frozen section pathology to guide selective lymph node dissection, Prof. Chen's team removes only what is necessary, preserving immune function while maintaining oncological completeness.
Intraoperative Frozen Pathology-Guided Surgery
A cornerstone of Prof. Chen's surgical approach is real-time decision-making during the operation:
- Suspicious lymph nodes are sampled and sent for immediate frozen section analysis during surgery
- The pathologist's intraoperative report guides the surgeon's decision on whether to proceed with full lymph node dissection or selective removal
- This approach avoids both under-treatment (missing involved nodes) and over-treatment (removing uninvolved nodes)
- The result is precise cancer removal with maximum preservation of immune architecture
Surgical Techniques Offered
- Uniportal VATS (single-incision thoracoscopic surgery) — the most minimally invasive approach, with a single small incision
- Multiportal VATS — standard thoracoscopic approach for more complex resections
- Robotic-assisted thoracic surgery (RATS) — enhanced precision for anatomically challenging tumors
- Anatomical segmentectomy — removal of a lung segment rather than a full lobe, preserving maximum lung function for small tumors (≤2 cm)
- Wedge resection — for very small peripheral tumors or patients with limited pulmonary reserve
- Lobectomy — standard resection for larger or more centrally located tumors
- Sleeve resection — bronchoplastic technique to avoid pneumonectomy for centrally located tumors
- Selective lymph node dissection guided by intraoperative frozen pathology (Minimally Invasive 3.0)
Who Is a Candidate for Prof. Chen's Surgical Approach?
- Patients with early-stage NSCLC (Stage I–II) who are surgical candidates
- Patients with ground-glass opacity (GGO) nodules detected on CT screening that require surgical evaluation
- Patients with multiple pulmonary nodules requiring staged or simultaneous resection
- Patients who have been told they need a lobectomy and want to explore whether a less extensive resection (segmentectomy) is oncologically appropriate
- Patients seeking a second surgical opinion on resectability or surgical approach
- Patients with borderline pulmonary function for whom lung-sparing surgery is critical
International Guideline Recognition
The incorporation of Prof. Chen's research into international clinical guidelines is a rare distinction that reflects the global impact of his work. It means that:
- His surgical standards have been independently reviewed and endorsed by international expert panels
- Patients treated by Prof. Chen receive care that is not only at the Chinese frontier but at the global frontier of thoracic surgery
- His protocols are being adopted by thoracic surgeons in other countries — a reversal of the traditional direction of medical knowledge transfer
How CMCS Coordinates Your Care
China Medical Concierge Shanghai (CMCS) is a health management company — not a hospital. We connect international patients with Shanghai's leading thoracic surgeons, including Prof. Chen Haiquan at Fudan University Shanghai Cancer Center, and manage every step of the process:
- Review of existing CT imaging, PET-CT, and pulmonary function test results
- Surgical consultation scheduling with Prof. Chen's thoracic surgery team
- Coordination with medical oncology for neoadjuvant or adjuvant therapy planning
- Coordination with radiation oncology for SBRT if surgery is not indicated
- Medical interpretation during pre-operative consultations and post-operative follow-up
- Logistics support: accommodation near FUSCC, visa assistance, and local transport
- Post-surgical follow-up and remote monitoring coordination
Get in Touch
If you have been diagnosed with early-stage lung cancer or a pulmonary nodule requiring surgical evaluation, contact our team for a confidential consultation.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
댓글 0개